Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
- 1 April 2014
- journal article
- Published by Elsevier in The Lancet
- Vol. 383 (9924) , 1230-1239
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South AfricaPLOS ONE, 2013
- Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infectionEmerging Infectious Diseases, 2013
- What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?PLOS ONE, 2013
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug ResistanceAntimicrobial Agents and Chemotherapy, 2012
- Mycobacterium tuberculosis Population Structure Determines the Outcome of Genetics-Based Second-Line Drug Resistance TestingAntimicrobial Agents and Chemotherapy, 2012
- Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosisMicrobial Drug Resistance, 2012
- The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?The Lancet, 2012
- Canadian Multicenter Laboratory Study for Standardized Second-Line Antimicrobial Susceptibility Testing of Mycobacterium tuberculosisJournal of Clinical Microbiology, 2011
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis BacilliChest, 2009
- Comprehensive Treatment of Extensively Drug-Resistant TuberculosisNew England Journal of Medicine, 2008